Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Tech Transfer Awards
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Stories of Discovery
    • Chen Lecture Videos
    • Public Health & Economic Impact Study
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Active Patent Commercialization Licenses

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • NIH IRP Access Planning Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2 AND/OR CD276 AND THEIR USE FOR TREATING SOLID TUMORS

  • Read more about CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2 AND/OR CD276 AND THEIR USE FOR TREATING SOLID TUMORS
US Application 63/644,728
Filed on 2024-05-09

Chimeric Antigen Receptors targeting FGFR4 and/or CD276 with CD28 HTM and CSD for childhood rhabdomyosarcoma

  • Read more about Chimeric Antigen Receptors targeting FGFR4 and/or CD276 with CD28 HTM and CSD for childhood rhabdomyosarcoma
US Application 63/634,330
Filed on 2024-04-15

MONOCLONAL ANTIBODIES THAT BIND THE JUXTA-MEMBRANE REGION OF MESOTHELIN AND USES THEREOF (RO4 antibody)

  • Read more about MONOCLONAL ANTIBODIES THAT BIND THE JUXTA-MEMBRANE REGION OF MESOTHELIN AND USES THEREOF (RO4 antibody)
US Application 63/550,703
Filed on 2024-02-07

QUANTITATIVE PARTICLE IDENTIFICATION DIGITAL AUTORADIOGRAPHY

  • Read more about QUANTITATIVE PARTICLE IDENTIFICATION DIGITAL AUTORADIOGRAPHY
US Application 63/651,184
Filed on 2024-05-23

BIVALENT COMPOUNDS THAT BIND NON-CANONICAL G-QUADRUPLEX STRUCTURES AND METHODS OF MAKING AND USING THE SAME

  • Read more about BIVALENT COMPOUNDS THAT BIND NON-CANONICAL G-QUADRUPLEX STRUCTURES AND METHODS OF MAKING AND USING THE SAME
US Application 63/610,555
Filed on 2023-12-15

TREATMENT OF ALVEOLAR SOFT PART SARCOMA (ASPS) WITH ATEZOLIZUMAB

  • Read more about TREATMENT OF ALVEOLAR SOFT PART SARCOMA (ASPS) WITH ATEZOLIZUMAB
US Application 63/608,127
Filed on 2023-12-08

PREDICTING DNA METHYLATION AND TUMOR TYPES FROM HISTOPATHOLOGY

  • Read more about PREDICTING DNA METHYLATION AND TUMOR TYPES FROM HISTOPATHOLOGY
US Application 63/626,277
Filed on 2024-01-29

Tixocortol Pivalate for use in the prevention and/or treatment of SARS-CoV-2 infections

  • Read more about Tixocortol Pivalate for use in the prevention and/or treatment of SARS-CoV-2 infections
US Application 63/599,446
Filed on 2023-11-15

FATTY ACID AND CYCLIZED DERIVATIVES OF THE IMMUNOMODULATORY PEPTIDE RP-182 WITH IMPROVED ANTI-TUMOR ACTIVITY, COMPOSITIONS, AND METHODS OF USE THEREOF

  • Read more about FATTY ACID AND CYCLIZED DERIVATIVES OF THE IMMUNOMODULATORY PEPTIDE RP-182 WITH IMPROVED ANTI-TUMOR ACTIVITY, COMPOSITIONS, AND METHODS OF USE THEREOF
US Application 63/656,535
Filed on 2024-06-05

ENGINEERED RNA DEVICES IN HUMAN T-CELLS TO CONTROL GENE EXPRESSION EXTERNALLY

  • Read more about ENGINEERED RNA DEVICES IN HUMAN T-CELLS TO CONTROL GENE EXPRESSION EXTERNALLY
US Application 63/683,318
Filed on 2024-08-15

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 82
  • Page 83
  • Page 84
  • Page 85
  • Page 86
  • Page 87
  • Page 88
  • Page 89
  • Page 90
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health